ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,213Medicare Part D Prescriptions Filled, Including Refills

Rank: 169 out of 1844

$790K Total Retail Price of All Prescriptions

Rank: 107 out of 1844

541 Patients Receiving at Least One Drug in Part D
89%Patients 65 Years and Older
14% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Indiana
Lower avg

Schedule Two
Controlled Substances

2% of this provider’s 541 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

13% of this provider’s 541 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

2% of this provider’s 10,273 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$70 was the average price of a prescription from this provider, compared to $60 among peers.

Prescriptions per Patient

21 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Indiana
LEVOTHYROXINE SODIUM 465 413 1 1
SIMVASTATIN 457 435 2 3
LISINOPRIL 434 416 3 4
MELOXICAM 332 304 4 28
AMLODIPINE BESYLATE 329 327 5 6
OMEPRAZOLE 310 266 6 5
HYDROCODONE-ACETAMINOPHEN 261 223 S3 7 2
METOPROLOL SUCCINATE 253 242 8 14
WARFARIN SODIUM 247 204 9 13
ZOLPIDEM TARTRATE 236 225 10 23
TRAMADOL HCL 195 185 11 18
HYDROCHLOROTHIAZIDE 192 172 12 9
METFORMIN HCL ER 175 137 13 46
NEXIUM 166 160 14 31
METOPROLOL TARTRATE 157 146 15 11
LOSARTAN POTASSIUM 132 132 16 24
ATORVASTATIN CALCIUM 129 127 17 12
PREDNISONE 124 108 18 40
GLIPIZIDE ER 117 112 19 79
LISINOPRIL-HYDROCHLOROTHIAZIDE 113 110 20 20
LOSARTAN-HYDROCHLOROTHIAZIDE 111 98 21 47
ATENOLOL 108 88 22 17
ALENDRONATE SODIUM 107 96 23 25
ALLOPURINOL 107 107 23 29
METFORMIN HCL 107 91 23 8
CRESTOR 104 89 26 30
SERTRALINE HCL 102 88 27 21
PRAVASTATIN SODIUM 101 91 28 10
CLOPIDOGREL 94 94 29 34
FUROSEMIDE 93 88 30 7
CLONIDINE HCL 93 92 30 64
CITALOPRAM HBR 92 88 32 19
DILTIAZEM 24HR ER 89 79 33 146
DONEPEZIL HCL 83 83 34 26
FENOFIBRATE 82 78 35 71
GABAPENTIN 82 69 35 15
CYMBALTA 82 49 35 36
JANUVIA 79 79 38 77
FLUTICASONE PROPIONATE 78 78 39 50
PLAVIX 78 75 39 61
AZITHROMYCIN 77 70 41 37
SINGULAIR 74 67 42 102
CELEBREX 71 64 43 91
ADVAIR DISKUS 69 62 44 51
VENLAFAXINE HCL ER 69 55 44 93
PROAIR HFA 68 66 46 45
CYCLOBENZAPRINE HCL 68 61 R 46 53
MONTELUKAST SODIUM 61 54 48 195
EVISTA 61 61 48 95
TAMSULOSIN HCL 58 58 50 27
PANTOPRAZOLE SODIUM 54 43 51 32
ISOSORBIDE MONONITRATE ER 54 54 51 59
LYRICA 53 41 53 92
TRIAMTERENE-HCTZ 53 53 53 48
VERAPAMIL ER 52 52 55 98
NAMENDA 52 52 55 33
SYMBICORT 52 51 55 134
LOVASTATIN 52 52 55 44
DIOVAN 51 51 59 58
CARVEDILOL 50 49 60 22
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 9, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.